Circulating leptin and angiogenic factors in preeclampsia patients

Hideki Nakatsukasa, Hisashi Masuyama, Norio Takamoto, Yuji Hiramatsu

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Leptin, one of adipocytokines, plays a wide range of important roles in reproductive biology. We have previously reported that low hypo-adiponectinemia might be involved in the pathophysiology of overweight preeclampsia (PE) patients. Moreover, recent reports have underscored the importance of circulating angiogenic factors in the pathophysiology of PE. Here, we examined whether leptin in conjunction with adiponectin and/or angiogenic factors plays some role in the pathophysiology of PE. We performed a cross-sectional study in 34 PE patients and normal pregnancies matched for gestational age and body mass index as controls. We measured serum concentrations of leptin, adiponectin, the angiogenic factors vascular endothelial growth factor (VEGF), placental growth factor, and the soluble VEGF receptors sF1t-1 and sFlk-1. We observed that leptin levels in PE patients were significantly higher compared with those in controls, but did not observe significant differences between normal- and overweight patients in both groups. We also showed a significant negative correlation between leptin and adiponectin in controls, but not in PE patients. There was a significant correlation between leptin and sFlt-1 in PE patients, while there were significant differences of body mass index, mean blood pressure and proteinuria between high and low leptin/sFlt-1 ratio group in PE patients. Moreover, there was a significant difference of leptin level between IUGR and normal growth group in PE patients. These results suggest that the circulating increased leptin might be derived mainly from the placenta and regulated by the placental hypoxic condition, whereas adiponectin might be derived mainly from adipose tissue; and that leptin might play some role through insulin resistance, autonomic activation, or direct effect on endothelium with other angiogenic factors in pathophysiology of PE compared with the exaggerated release of adiponectin from adipose tissue.

Original languageEnglish
Pages (from-to)565-573
Number of pages9
JournalEndocrine Journal
Volume55
Issue number3
DOIs
Publication statusPublished - 2008

Fingerprint

Angiogenesis Inducing Agents
Leptin
Pre-Eclampsia
Adiponectin
Adipose Tissue
Body Mass Index
Vascular Endothelial Growth Factor Receptor-1
Adipokines
Fetal Growth Retardation
Proteinuria
Placenta
Vascular Endothelial Growth Factor A
Gestational Age
Endothelium
Insulin Resistance
Intercellular Signaling Peptides and Proteins
Cross-Sectional Studies
Blood Pressure
Pregnancy

Keywords

  • Adiponectin
  • Angiogenic factor
  • Leptin
  • Preeclampsia

ASJC Scopus subject areas

  • Endocrinology

Cite this

Circulating leptin and angiogenic factors in preeclampsia patients. / Nakatsukasa, Hideki; Masuyama, Hisashi; Takamoto, Norio; Hiramatsu, Yuji.

In: Endocrine Journal, Vol. 55, No. 3, 2008, p. 565-573.

Research output: Contribution to journalArticle

Nakatsukasa, Hideki ; Masuyama, Hisashi ; Takamoto, Norio ; Hiramatsu, Yuji. / Circulating leptin and angiogenic factors in preeclampsia patients. In: Endocrine Journal. 2008 ; Vol. 55, No. 3. pp. 565-573.
@article{334485ac21ea45f0b05c95db70a81d46,
title = "Circulating leptin and angiogenic factors in preeclampsia patients",
abstract = "Leptin, one of adipocytokines, plays a wide range of important roles in reproductive biology. We have previously reported that low hypo-adiponectinemia might be involved in the pathophysiology of overweight preeclampsia (PE) patients. Moreover, recent reports have underscored the importance of circulating angiogenic factors in the pathophysiology of PE. Here, we examined whether leptin in conjunction with adiponectin and/or angiogenic factors plays some role in the pathophysiology of PE. We performed a cross-sectional study in 34 PE patients and normal pregnancies matched for gestational age and body mass index as controls. We measured serum concentrations of leptin, adiponectin, the angiogenic factors vascular endothelial growth factor (VEGF), placental growth factor, and the soluble VEGF receptors sF1t-1 and sFlk-1. We observed that leptin levels in PE patients were significantly higher compared with those in controls, but did not observe significant differences between normal- and overweight patients in both groups. We also showed a significant negative correlation between leptin and adiponectin in controls, but not in PE patients. There was a significant correlation between leptin and sFlt-1 in PE patients, while there were significant differences of body mass index, mean blood pressure and proteinuria between high and low leptin/sFlt-1 ratio group in PE patients. Moreover, there was a significant difference of leptin level between IUGR and normal growth group in PE patients. These results suggest that the circulating increased leptin might be derived mainly from the placenta and regulated by the placental hypoxic condition, whereas adiponectin might be derived mainly from adipose tissue; and that leptin might play some role through insulin resistance, autonomic activation, or direct effect on endothelium with other angiogenic factors in pathophysiology of PE compared with the exaggerated release of adiponectin from adipose tissue.",
keywords = "Adiponectin, Angiogenic factor, Leptin, Preeclampsia",
author = "Hideki Nakatsukasa and Hisashi Masuyama and Norio Takamoto and Yuji Hiramatsu",
year = "2008",
doi = "10.1507/endocrj.K07E-136",
language = "English",
volume = "55",
pages = "565--573",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Circulating leptin and angiogenic factors in preeclampsia patients

AU - Nakatsukasa, Hideki

AU - Masuyama, Hisashi

AU - Takamoto, Norio

AU - Hiramatsu, Yuji

PY - 2008

Y1 - 2008

N2 - Leptin, one of adipocytokines, plays a wide range of important roles in reproductive biology. We have previously reported that low hypo-adiponectinemia might be involved in the pathophysiology of overweight preeclampsia (PE) patients. Moreover, recent reports have underscored the importance of circulating angiogenic factors in the pathophysiology of PE. Here, we examined whether leptin in conjunction with adiponectin and/or angiogenic factors plays some role in the pathophysiology of PE. We performed a cross-sectional study in 34 PE patients and normal pregnancies matched for gestational age and body mass index as controls. We measured serum concentrations of leptin, adiponectin, the angiogenic factors vascular endothelial growth factor (VEGF), placental growth factor, and the soluble VEGF receptors sF1t-1 and sFlk-1. We observed that leptin levels in PE patients were significantly higher compared with those in controls, but did not observe significant differences between normal- and overweight patients in both groups. We also showed a significant negative correlation between leptin and adiponectin in controls, but not in PE patients. There was a significant correlation between leptin and sFlt-1 in PE patients, while there were significant differences of body mass index, mean blood pressure and proteinuria between high and low leptin/sFlt-1 ratio group in PE patients. Moreover, there was a significant difference of leptin level between IUGR and normal growth group in PE patients. These results suggest that the circulating increased leptin might be derived mainly from the placenta and regulated by the placental hypoxic condition, whereas adiponectin might be derived mainly from adipose tissue; and that leptin might play some role through insulin resistance, autonomic activation, or direct effect on endothelium with other angiogenic factors in pathophysiology of PE compared with the exaggerated release of adiponectin from adipose tissue.

AB - Leptin, one of adipocytokines, plays a wide range of important roles in reproductive biology. We have previously reported that low hypo-adiponectinemia might be involved in the pathophysiology of overweight preeclampsia (PE) patients. Moreover, recent reports have underscored the importance of circulating angiogenic factors in the pathophysiology of PE. Here, we examined whether leptin in conjunction with adiponectin and/or angiogenic factors plays some role in the pathophysiology of PE. We performed a cross-sectional study in 34 PE patients and normal pregnancies matched for gestational age and body mass index as controls. We measured serum concentrations of leptin, adiponectin, the angiogenic factors vascular endothelial growth factor (VEGF), placental growth factor, and the soluble VEGF receptors sF1t-1 and sFlk-1. We observed that leptin levels in PE patients were significantly higher compared with those in controls, but did not observe significant differences between normal- and overweight patients in both groups. We also showed a significant negative correlation between leptin and adiponectin in controls, but not in PE patients. There was a significant correlation between leptin and sFlt-1 in PE patients, while there were significant differences of body mass index, mean blood pressure and proteinuria between high and low leptin/sFlt-1 ratio group in PE patients. Moreover, there was a significant difference of leptin level between IUGR and normal growth group in PE patients. These results suggest that the circulating increased leptin might be derived mainly from the placenta and regulated by the placental hypoxic condition, whereas adiponectin might be derived mainly from adipose tissue; and that leptin might play some role through insulin resistance, autonomic activation, or direct effect on endothelium with other angiogenic factors in pathophysiology of PE compared with the exaggerated release of adiponectin from adipose tissue.

KW - Adiponectin

KW - Angiogenic factor

KW - Leptin

KW - Preeclampsia

UR - http://www.scopus.com/inward/record.url?scp=46749112282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749112282&partnerID=8YFLogxK

U2 - 10.1507/endocrj.K07E-136

DO - 10.1507/endocrj.K07E-136

M3 - Article

C2 - 18490835

AN - SCOPUS:46749112282

VL - 55

SP - 565

EP - 573

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 3

ER -